{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:25:58Z","timestamp":1751631958459,"version":"3.40.3"},"publisher-location":"Totowa, NJ","reference-count":45,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781603272803"},{"type":"electronic","value":"9781603272810"}],"license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-60327-281-0_19","type":"book-chapter","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T09:35:11Z","timestamp":1232703311000},"page":"279-288","source":"Crossref","is-referenced-by-count":3,"title":["GSTP1 Hypermethylation for Prostate Cancer Detection"],"prefix":"10.1007","author":[{"given":"Rui","family":"Henrique","sequence":"first","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/5947","volume":"21","author":"P Jones","year":"1999","unstructured":"Jones P, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163\u2013167.","journal-title":"Nat Genet"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1024","volume":"196","author":"M Esteller","year":"2002","unstructured":"Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002;196:1\u20137.","journal-title":"J Pathol"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042\u20132054.","journal-title":"N Engl J Med"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1201\/9780203487013.ch2","volume-title":"DNA methylation.","author":"C Jer\u00f3nimo","year":"2004","unstructured":"Jer\u00f3nimo C, Henrique R, Sidransky D. Uses of DNA methylation in cancer diagnosis and risk assessment. In: Esteller M, ed. DNA methylation. Approaches, Methods and Applications. Boca Raton: CRC Press, 2004:11\u201326."},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/10409239009090605","volume":"25","author":"B Coles","year":"1990","unstructured":"Coles B, Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 1990;25:47\u201370.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"19_CR6","first-page":"103","volume":"61","author":"CP Nelson","year":"2001","unstructured":"Nelson CP, Kidd LC, Sauvegeot J, Isaacs WB, De Marzo AM, Groopman JD, Nelson WG, Kensler TW. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 2001;61:103\u2013109.","journal-title":"Cancer Res"},{"key":"19_CR7","first-page":"266","volume":"60","author":"GR Stuart","year":"2000","unstructured":"Stuart GR, Holcroft J, de Boer JG, Glickman BW. Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 2000;60:266\u2013268.","journal-title":"Cancer Res"},{"key":"19_CR8","first-page":"8611","volume":"61","author":"X Lin","year":"2001","unstructured":"Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res 2001;61:8611\u20138616.","journal-title":"Cancer Res"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1749-6632.2001.tb02734.x","volume":"952","author":"WG Nelson","year":"2001","unstructured":"Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD, Kensler TW. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Ann N Y Acad Sci 2001;952:135\u2013144.","journal-title":"Ann N Y Acad Sci"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"11733","DOI":"10.1073\/pnas.91.24.11733","volume":"91","author":"WH Lee","year":"1994","unstructured":"Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994;91:11733\u201311737.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"24893","DOI":"10.1074\/jbc.M906538199","volume":"275","author":"DS Millar","year":"2000","unstructured":"Millar DS, Paul CL, Molloy PL, Clark SJ. A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5\u2019-end of the GSTP1 CpG island. J Biol Chem 2000;275:24893\u201324899.","journal-title":"J Biol Chem"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0002-9440(10)63028-3","volume":"159","author":"X Lin","year":"2001","unstructured":"Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, DeWeese TL, De Marzo AM, Nelson WG. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 2001;159:1815\u20131826.","journal-title":"Am J Pathol"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"22322","DOI":"10.1074\/jbc.272.35.22322","volume":"272","author":"JR Graff","year":"1997","unstructured":"Graff JR, Herman JG, Myohanen S, Baylin SB, Vertino PM. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem 1997;272:22322\u201322329.","journal-title":"J Biol Chem"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1073\/pnas.86.10.3728","volume":"86","author":"M Toth","year":"1989","unstructured":"Toth M, Lichtenberg U, Doerfler W. Genomic sequencing reveals a 5-methylcytosine-free domain in active promoters and the spreading of preimposed methylation patterns. Proc Natl Acad Sci USA 1989;86:3728\u20133732.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1158\/0008-5472.CAN-03-3690","volume":"64","author":"C Stirzaker","year":"2004","unstructured":"Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res 2004;64:3871\u20133877.","journal-title":"Cancer Res"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2144\/02333rv01","volume":"33","author":"MF Fraga","year":"2002","unstructured":"Fraga MF, Esteller M. DNA methylation: a profile of methods and applications. Biotechniques 2002;33:632\u2013649.","journal-title":"Biotechniques"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1093\/nar\/24.24.5064","volume":"24","author":"A Olek","year":"1996","unstructured":"Olek A, Oswald J, Walter J. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 1996;24:5064\u20135066.","journal-title":"Nucleic Acids Res"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93: 9821\u20139826.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/jnci\/93.22.1747","volume":"93","author":"C Jer\u00f3nimo","year":"2001","unstructured":"Jer\u00f3nimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, Sidransky D. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 2001;93:1747\u20131752.","journal-title":"J Natl Cancer Inst"},{"key":"19_CR20","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djg082","volume":"95","author":"SV Harden","year":"2003","unstructured":"Harden SV, Sanderson H, Goodman SN, Partin AA, Walsh PC, Epstein JI, Sidransky D. Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst 2003;95:1634\u20131637.","journal-title":"J Natl Cancer Inst"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1541-7786.MCR-05-0113","volume":"4","author":"R Henrique","year":"2006","unstructured":"Henrique R, Jer\u00f3nimo C, Teixeira MR, Hoque MO, Carvalho AL, Pais I, Ribeiro FR, Oliveira J, Lopes C, Sidransky D. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Mol Cancer Res 2006;4:1\u20138.","journal-title":"Mol Cancer Res"},{"key":"19_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/jnci\/djj051","volume":"98","author":"JA Hanson","year":"2006","unstructured":"Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG. Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 2006;98:255\u2013261.","journal-title":"J Natl Cancer Inst"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","volume":"28","author":"CA Eads","year":"2000","unstructured":"Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.","journal-title":"Nucleic Acids Res"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1093\/nar\/gki987","volume":"33","author":"DJ Weisenberger","year":"2005","unstructured":"Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005;33: 6823\u20136836.","journal-title":"Nucleic Acids Res"},{"key":"19_CR25","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1093\/nar\/gnj022","volume":"34","author":"S Yegnasubramanian","year":"2006","unstructured":"Yegnasubramanian S, Lin X, Haffner MC, DeMarzo AM, Nelson WG. Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation. Nucleic Acids Res 2006;34:E19.","journal-title":"Nucleic Acids Res"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/01.ju.0000049627.90307.4d","volume":"169","author":"SV Harden","year":"2003","unstructured":"Harden SV, Guo Z, Epstein JI, Sidransky D. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 2003;169:1138\u20131142.","journal-title":"J Urol"},{"key":"19_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa030660","volume":"349","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349: 215\u2013224.","journal-title":"N Engl J Med"},{"key":"19_CR28","first-page":"5941","volume":"60","author":"C Goessl","year":"2000","unstructured":"Goessl C, Krause H, Muller M, Heicappell R, Schrader M, Sachsinger J, Miller K. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res 2000;60:5941\u20135945.","journal-title":"Cancer Res"},{"key":"19_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0090-4295(01)01268-7","volume":"58","author":"C Goessl","year":"2001","unstructured":"Goessl C, Muller M, Heicappell R, Krause H, Straub B, Schrader M, Miller K. DNA-based detection of prostate cancer in urine after prostatic massage. Urology 2001;58:335\u2013338.","journal-title":"Urology"},{"key":"19_CR30","first-page":"2727","volume":"7","author":"P Cairns","year":"2001","unstructured":"Cairns P, Esteller M, Herman JG, Schoenberg M, Jer\u00f3nimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 2001;7:2727\u20132730.","journal-title":"Clin Cancer Res"},{"key":"19_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0090-4295(02)01949-0","volume":"60","author":"C Jer\u00f3nimo","year":"2002","unstructured":"Jer\u00f3nimo C, Usadel H, Henrique R, Silva C, Oliveira J, Lopes C, Sidransky D. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 2002;60:1131\u20131135.","journal-title":"Urology"},{"key":"19_CR32","first-page":"2673","volume":"9","author":"ML Gonzalgo","year":"2003","unstructured":"Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens. Clin Cancer Res 2003;9:2673\u20132677.","journal-title":"Clin Cancer Res"},{"key":"19_CR33","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1200\/JCO.2005.07.009","volume":"23","author":"MO Hoque","year":"2005","unstructured":"Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. J Clin Oncol 2005;23:6569\u20136575.","journal-title":"J Clin Oncol"},{"key":"19_CR34","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/1078-0432.CCR-06-2467","volume":"13","author":"M Roupr\u00eat","year":"2007","unstructured":"Roupr\u00eat M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Clin Cancer Res 2007;13:1720\u20131725.","journal-title":"Clin Cancer Res"},{"key":"19_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ijc.21017","volume":"116","author":"H Enokida","year":"2005","unstructured":"Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 2005;116:174\u2013181.","journal-title":"Int J Cancer"},{"key":"19_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.eururo.2004.06.014","volume":"46","author":"R Henrique","year":"2004","unstructured":"Henrique R, Jer\u00f3nimo C. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur Urol 2004;46:660\u2013669.","journal-title":"Eur Urol"},{"key":"19_CR37","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-03-3972","volume":"64","author":"S Yegnasubramanian","year":"2004","unstructured":"Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, DeMarzo AM, Isaacs WB, Nelson WG. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 2004;64:1975\u20131986.","journal-title":"Cancer Res"},{"key":"19_CR38","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1158\/1078-0432.CCR-04-0108","volume":"10","author":"Y Tokumaru","year":"2004","unstructured":"Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI, Sidransky D. Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma. Clin Cancer Res 2004;10:5518\u20135522.","journal-title":"Clin Cancer Res"},{"key":"19_CR39","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1158\/1078-0432.CCR-04-0894","volume":"10","author":"C Jer\u00f3nimo","year":"2004","unstructured":"Jer\u00f3nimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D. A quantitative methylation profile of prostate cancer. Clin Cancer Res 2004;10:8472\u20138478.","journal-title":"Clin Cancer Res"},{"key":"19_CR40","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1158\/1078-0432.CCR-04-1832","volume":"11","author":"PJ Bastian","year":"2005","unstructured":"Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Muller SC, von Ruecker A. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Clin Cancer Res 2005;11:4097\u20134106.","journal-title":"Clin Cancer Res"},{"key":"19_CR41","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-05-0658","volume":"11","author":"H Enokida","year":"2005","unstructured":"Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res 2005;11:6582\u20136588.","journal-title":"Clin Cancer Res"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","volume":"94","author":"R Etzioni","year":"2002","unstructured":"Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981\u2013990.","journal-title":"J Natl Cancer Inst"},{"key":"19_CR43","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/1078-0432.CCR-03-0643","volume":"10","author":"C Jer\u00f3nimo","year":"2004","unstructured":"Jer\u00f3nimo C, Henrique R, Hoque MO, Ribeiro FR, Oliveira J, Fonseca D, Teixeira MR, Lopes C, Sidransky D. Quantitative RAR\n                  \n                    \n                      \n                    \n                    $\\beta$\n                  \n                  2 hypermethylation: a promising prostate cancer marker. Clin Cancer Res 2004;10:4010\u20134014.","journal-title":"Clin Cancer Res"},{"key":"19_CR44","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1158\/1078-0432.CCR-04-2446","volume":"11","author":"PJ Bastian","year":"2005","unstructured":"Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 2005;11:4037\u20134043.","journal-title":"Clin Cancer Res"},{"key":"19_CR45","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","volume":"93","author":"MS Pepe","year":"2002","unstructured":"Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2002;93:1054\u20131061.","journal-title":"J Natl Cancer Inst"}],"container-title":["Prostate Cancer Screening"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60327-281-0_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T05:35:53Z","timestamp":1580362553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60327-281-0_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781603272803","9781603272810"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-60327-281-0_19","relation":{},"subject":[],"published":{"date-parts":[[2009]]}}}